Literature DB >> 22577179

A review and update on the current status of stem cell therapy and the retina.

J M Ong1, L da Cruz.   

Abstract

INTRODUCTION OR
BACKGROUND: Many diseases of the retina result in irreversible visual loss. Stem cell (SC) therapy is a rapidly developing field and represents a novel approach to replace non-functioning neuro-retinal cells. SOURCES OF DATA: A systematic computerized literature search was conducted on PubMed (http://www.ncbi.nlm.nih.gov/pubmed/). AREAS OF AGREEMENT: The use of stem cells (SCs) in animal models of retinal diseases has resulted in improvement in visual function and performance. SC therapy represents an exciting prospect in restoring vision. Areas of controversy The use of human embryonic SCs raises ethical concerns. GROWING POINTS: Human trials using SCs in retinal diseases have recently been approved. AREAS TIMELY FOR DEVELOPING RESEARCH: The success of SCs in retinal therapy depends not only on implanted cell survival, but also on how well SCs migrate, integrate and form synapses. Further research will be needed to overcome these hurdles.

Entities:  

Mesh:

Year:  2012        PMID: 22577179     DOI: 10.1093/bmb/lds013

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  10 in total

1.  Proceedings of the First International Optogenetic Therapies for Vision Symposium.

Authors:  Peter J Francis; Brian Mansfield; Stephen Rose
Journal:  Transl Vis Sci Technol       Date:  2013-11-21       Impact factor: 3.283

Review 2.  Current focus of stem cell application in retinal repair.

Authors:  María L Alonso-Alonso; Girish K Srivastava
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 3.  Topographical control of ocular cell types for tissue engineering.

Authors:  Kevin J McHugh; Magali Saint-Geniez; Sarah L Tao
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2013-06-07       Impact factor: 3.368

4.  Otx2 and Onecut1 promote the fates of cone photoreceptors and horizontal cells and repress rod photoreceptors.

Authors:  Mark M Emerson; Natalia Surzenko; Jillian J Goetz; Jeffrey Trimarchi; Constance L Cepko
Journal:  Dev Cell       Date:  2013-07-15       Impact factor: 12.270

5.  A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina.

Authors:  Sui Wang; Cem Sengel; Mark M Emerson; Constance L Cepko
Journal:  Dev Cell       Date:  2014-08-21       Impact factor: 12.270

6.  Telocytes and stem cells in limbus and uvea of mouse eye.

Authors:  María José Luesma; Mihaela Gherghiceanu; Laurenţiu M Popescu
Journal:  J Cell Mol Med       Date:  2013-08       Impact factor: 5.310

Review 7.  Advances in gene therapy technologies to treat retinitis pigmentosa.

Authors:  Hilda Petrs-Silva; Rafael Linden
Journal:  Clin Ophthalmol       Date:  2013-12-24

8.  Functional and morphological analysis of the subretinal injection of human retinal progenitor cells under Cyclosporin A treatment.

Authors:  Rui Huang; Petr Baranov; Kunbei Lai; Xinmei Zhang; Jian Ge; Michael J Young
Journal:  Mol Vis       Date:  2014-09-19       Impact factor: 2.367

9.  Immunocytochemical Profiling of Cultured Mouse Primary Retinal Cells.

Authors:  Marina C Zalis; Sebastian Johansson; Ulrica Englund-Johansson
Journal:  J Histochem Cytochem       Date:  2017-02-02       Impact factor: 2.479

Review 10.  The promise of stem cell-based therapeutics in ophthalmology.

Authors:  Israel Aharony; Shalom Michowiz; Nitza Goldenberg-Cohen
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.